Pure Global

Influence of Anesthesia Drugs on Impedance Aggregometry - Trial NCT01454427

Access comprehensive clinical trial information for NCT01454427 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Lausanne Hospitals and is currently Completed. The study focuses on Platelet Dysfunction. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT01454427
Completed
Trial Details
ClinicalTrials.gov โ€ข NCT01454427
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Influence of Anesthesia Drugs on Impedance Aggregometry
The Influence of Drugs Routinely Used in Cardiac Anesthesia on Impedance Aggregometry.

Study Focus

Platelet Dysfunction

Observational

Sponsor & Location

University of Lausanne Hospitals

Lausanne, Switzerland

Timeline & Enrollment

N/A

Oct 01, 2010

May 01, 2011

20 participants

Primary Outcome

Drug induced platelet dysfunction as measured by impedance aggregometry.

Summary

Impedance aggregometry (IA) (Multiplateยฎ)is a new whole blood platelet function test with
 potential use in anesthesia and intensive care. Most anesthetic drugs have been shown to have
 in vitro antiplatelet activity. The goal of this in vitro study is to evaluate the effect of
 several drugs, frequently used in cardiac anesthesia and intensive care, on platelet function
 as measured by IA

ICD-10 Classifications

Qualitative platelet defects
Antithrombotic drugs [platelet-aggregation inhibitors]
Essential (haemorrhagic) thrombocythaemia
Other thrombophilia
Haemorrhagic disorder due to circulating anticoagulants

Data Source

ClinicalTrials.gov

NCT01454427

Non-Device Trial